KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Dividends payables (2016 - 2025)

Merck (MRK) has disclosed Dividends payables for 17 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Dividends payables rose 2.69% to $2.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 billion, a 2.69% increase, with the full-year FY2025 number at $2.1 billion, up 2.69% from a year prior.
  • Dividends payables was $2.1 billion for Q4 2025 at Merck, up from $2.0 billion in the prior quarter.
  • In the past five years, Dividends payables ranged from a high of $2.1 billion in Q4 2025 to a low of $1.7 billion in Q3 2021.
  • A 5-year average of $1.9 billion and a median of $1.9 billion in 2022 define the central range for Dividends payables.
  • Peak YoY movement for Dividends payables: increased 7.68% in 2023, then increased 2.69% in 2025.
  • Merck's Dividends payables stood at $1.8 billion in 2021, then increased by 6.56% to $1.9 billion in 2022, then rose by 5.36% to $2.0 billion in 2023, then increased by 4.99% to $2.1 billion in 2024, then increased by 2.69% to $2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Dividends payables are $2.1 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.1 billion (Q2 2025).